These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1034 related articles for article (PubMed ID: 18337202)

  • 1. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.
    Sheng ZF; Xu K; Ma YL; Liu JH; Dai RC; Zhang YH; Jiang YB; Liao EY
    Osteoporos Int; 2009 Jan; 20(1):151-9. PubMed ID: 18496637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
    Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
    Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
    Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
    Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice.
    Lloyd SA; Yuan YY; Kostenuik PJ; Ominsky MS; Lau AG; Morony S; Stolina M; Asuncion FJ; Bateman TA
    Calcif Tissue Int; 2008 May; 82(5):361-72. PubMed ID: 18465074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study on effect of osthole and genistein on peak bone mass in rats].
    Cheng K; Ge BF; Zhen P; Chen KM; Ma XN; Zhou J; Song P; Ma HP
    Zhongguo Gu Shang; 2014 Jul; 27(7):587-91. PubMed ID: 25338447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genistein and Silicon Synergistically Protects Against Ovariectomy-Induced Bone Loss Through Upregulating OPG/RANKL Ratio.
    Chen C; Zheng H; Qi S
    Biol Trace Elem Res; 2019 Apr; 188(2):441-450. PubMed ID: 30014283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
    J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone mass change and its possible mechanisms in murine knockout apolipoprotein E(ApoE-/-)].
    Wang M; Li XP; Zhao LL; Liao EY; Luo XH
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2963-7. PubMed ID: 20137704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotoxicosis Involves β2-Adrenoceptor Signaling to Negatively Affect Microarchitecture and Biomechanical Properties of the Femur.
    Neofiti-Papi B; Albuquerque RP; Miranda-Rodrigues M; Gonçalves NJN; Jorgetti V; Brum PC; Ferreira JCB; Gouveia CHA
    Thyroid; 2019 Aug; 29(8):1060-1072. PubMed ID: 31264512
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of a low-dose anti-resorptive drug regimen reveals synergistic suppression of bone formation when coupled with disuse.
    Lloyd SA; Travis ND; Lu T; Bateman TA
    J Appl Physiol (1985); 2008 Mar; 104(3):729-38. PubMed ID: 18174391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
    Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison research with icariin and genistein by anti-inflammatory reaction and angiogenesis pathway to inhibit bone loss on ovariectomized rats].
    Cheng K; Chen KM; Ge BF; Zhen P; Gao YH; Ma HP
    Zhong Yao Cai; 2014 Apr; 37(4):627-31. PubMed ID: 25345138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Effects of Genistein and Zinc on Bone Metabolism and the Femoral Metaphyseal Histomorphology in the Ovariectomized Rats.
    Qi S
    Biol Trace Elem Res; 2018 Jun; 183(2):288-295. PubMed ID: 28842860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate treatment increases the size of the mandibular condyle and normalizes growth of the mandibular ramus in osteoprotegerin-deficient mice.
    Kimura M; Miyazawa K; Tabuchi M; Maeda H; Kameyama Y; Goto S
    Calcif Tissue Int; 2008 Feb; 82(2):137-47. PubMed ID: 18183447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation.
    Li B; Yu S
    Biol Pharm Bull; 2003 Jun; 26(6):780-6. PubMed ID: 12808286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of 17beta-estradiol, raloxifene and genistein on bone 3D microarchitecture and volumetric bone mineral density in the ovariectomized mice.
    Cano A; Dapía S; Noguera I; Pineda B; Hermenegildo C; del Val R; Caeiro JR; García-Pérez MA
    Osteoporos Int; 2008 Jun; 19(6):793-800. PubMed ID: 17968609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative effects of exercise training and genistein administration on bone mass in ovariectomized mice.
    Wu J; Wang XX; Takasaki M; Ohta A; Higuchi M; Ishimi Y
    J Bone Miner Res; 2001 Oct; 16(10):1829-36. PubMed ID: 11585347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin is an effective countermeasure for spaceflight-induced bone loss in mice.
    Lloyd SA; Morony SE; Ferguson VL; Simske SJ; Stodieck LS; Warmington KS; Livingston EW; Lacey DL; Kostenuik PJ; Bateman TA
    Bone; 2015 Dec; 81():562-572. PubMed ID: 26318907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.